About Endra (NASDAQ:NDRA)
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based thermos-acoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. ENDRA Life Sciences Inc. has collaborative research agreement with General Electric Company. The company was incorporated in 2007 and is based in Ann Arbor, Michigan.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:NDRA
CUSIPN/A
Phone734-335-0468
Debt
Debt-to-Equity RatioN/A
Current Ratio7.00%
Quick Ratio6.77%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$350,000.00
Price / Sales27.78
Cash FlowN/A
Price / CashN/A
Book Value$1.35 per share
Price / Book1.84
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-5,370,000.00
Net MarginsN/A
Return on Equity-114.14%
Return on Assets-97.43%
Miscellaneous
Employees13
Outstanding Shares3,920,000
Endra (NASDAQ:NDRA) Frequently Asked Questions
What is Endra's stock symbol?
Endra trades on the NASDAQ under the ticker symbol "NDRA."
When is Endra's next earnings date?
Who are some of Endra's key competitors?
Some companies that are related to Endra include Stereotaxis (STXS), Soleno Therapeutics (SLNO), Digirad (DRAD), Nexeon MedSystems (NXNN), Dynatronics (DYNT), Aradigm (ARDM), EnteroMedics (RSLS), CHF Solutions (CHFS), FC Global Realty (FCRE), Vasomedical (VASO), Non-Invasive Monitoring System (NIMU), Precision Optics (PEYE), Escalon Medical (ESMC), Trimedyne (TMED) and Spectrascience (SCIE).
Who are Endra's key executives?
Endra's management team includes the folowing people:
- Mr. Francois Michelon, Chairman and Chief Exec. Officer (Age 52)
- Mr. David R. Wells, Interim Chief Financial Officer (Age 56)
- Mr. Michael Thornton Ph.d., Chief Technology Officer (Age 50)
- Dr. Jonathan Behr Ph.D., Co-Founder
- Dr. Paul Picot, Chief Engineer
When did Endra IPO?
(NDRA) raised $10 million in an initial public offering (IPO) on Friday, February 3rd 2017. The company issued 2,000,000 shares at a price of $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities acted as the underwriters for the IPO.
Has Endra been receiving favorable news coverage?
Press coverage about NDRA stock has trended somewhat negative on Thursday, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Endra earned a news sentiment score of -0.04 on Accern's scale. They also assigned media stories about the company an impact score of 44.91 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of Endra?
Shares of NDRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Endra's stock price today?
One share of NDRA stock can currently be purchased for approximately $2.48.
How big of a company is Endra?
Endra has a market capitalization of $9.65 million and generates $350,000.00 in revenue each year. Endra employs 13 workers across the globe.
How can I contact Endra?
Endra's mailing address is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. The company can be reached via phone at 734-335-0468 or via email at [email protected]
MarketBeat Community Rating for Endra (NDRA)
MarketBeat's community ratings are surveys of what our community members think about Endra and other stocks. Vote "Outperform" if you believe NDRA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDRA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Endra (NASDAQ:NDRA) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/26/2016 forward)
Endra (NASDAQ:NDRA) Earnings History and Estimates Chart
Endra (NASDAQ NDRA) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 6/19/2018 | | | | | | | | |
| 11/14/2017 | Q3 2017 | | ($0.23) | | $0.29 million | View | N/A |  |
| 8/7/2017 | Q2 2017 | | ($0.59) | | $0.06 million | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Endra (NASDAQ:NDRA) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Endra (NASDAQ NDRA) Insider Trading and Institutional Ownership History
Institutional Ownership Percentage: 0.64%
Endra (NASDAQ NDRA) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Endra (NASDAQ NDRA) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | ENDRA Life Sciences to Host First Quarter 2018 Results Conference Call on Tuesday, May 15, 2018 at 4:30 p.m. ET
finance.yahoo.com - April 26 at 9:52 AM |
| ENDRA Life Sciences to Showcase Photoacoustic Imaging Technology at American Association for Cancer Research (AACR) Annual Meeting on April 14-18 in Chicago
finance.yahoo.com - April 9 at 9:18 AM |
| ENDRA Life Sciences to Present at The MicroCap Conference on Tuesday, April 10, 2018
finance.yahoo.com - April 2 at 3:24 PM |
| ENDRA Life Sciences Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 21 at 8:30 AM |
| ENDRA Life Sciences Inc (NASDAQ:NDRA): Does The -48.17% Earnings Decline Make It An Underperformer?
finance.yahoo.com - March 8 at 3:28 PM |
| ENDRA Life Sciences to Host Fourth Quarter and Full Year 2017 Results Conference Call on Tuesday, March 20, 2018 at 4:30 p.m. ET
finance.yahoo.com - March 7 at 8:48 AM |
| ENDRA Life Sciences to Present at the Inaugural LD Micro Virtual Conference on Tuesday, March 6, 2018 at 5:00 p.m. ET
finance.yahoo.com - February 27 at 3:28 PM |
| ENDRA Life Sciences Granted Two U.S. Patents for Non-Invasive Fat Assessment to Support TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - February 15 at 9:47 AM |
| ENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRA's TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - February 5 at 5:23 PM |
| Who Are The Top Investors In ENDRA Life Sciences Inc (NASDAQ:NDRA)?
finance.yahoo.com - December 28 at 5:18 PM |
| What Did ENDRA Life Sciences Inc’s (NDRA) CEO Take Home Last Year?
finance.yahoo.com - December 9 at 8:50 AM |
| How ENDRA Life Sciences Inc’s (NDRA) EPS Dropped 45.2%, Did Its Industry Show Weakness Too?
finance.yahoo.com - November 30 at 5:55 PM |
| ENDRA Life Sciences to Present at the 10th Annual LD Micro Main Event on December 6, 2017
finance.yahoo.com - November 23 at 6:47 AM |
| Should Your Next Investment In The Healthcare Industry Be In ENDRA Life Sciences Inc (NDRA)?
finance.yahoo.com - November 18 at 7:08 AM |
| ENDRA Life Sciences Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 18 at 7:08 AM |
| ENDRA Life Sciences Contracts The Centre for Imaging Technology Commercialization (CIMTEC) to Initiate Human Studies with ENDRA's Clinical TAEUS(TM) Device Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - November 9 at 7:31 AM |
| ENDRA Life Sciences Partners with StarFish Medical and CriTech Research to Commence Development of TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
finance.yahoo.com - November 4 at 7:44 AM |
| ENDRA Life Sciences to Host Third Quarter 2017 Results Conference Call on Wednesday, November 15, 2017 at 4:30 p.m. ET
finance.yahoo.com - October 24 at 7:36 AM |
 | ENDRA Life Sciences Completes Delivery and Installation of its Next Generation Nexus 128+ to Leading Research ... - Baystreet.ca
www.baystreet.ca - September 30 at 5:31 PM |
Endra (NASDAQ:NDRA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Endra (NASDAQ NDRA) Stock Chart for Thursday, April, 26, 2018
Loading chart…
